653 results on '"Kim, Kang Mo"'
Search Results
102. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors
103. Eupatilin attenuates bile acid-induced hepatocyte apoptosis
104. Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma
105. Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma
106. Stereotactic Body Radiation Therapy as a Salvage Treatment for Single Viable Hepatocellular Carcinoma at the Site of Incomplete Transarterial Chemoembolization
107. Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis
108. Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study
109. SAT-155 - Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
110. WED-121 - Prediction of hepatocellular carcinoma in chronic hepatitis B patients following HBsAg seroclearance: Lage score
111. THU-330 - Long-term outcomes of patients with Wilson disease: a single center analysis of 361 Korean patients
112. THU-140 - Outcomes between surgical resection and transarterial chemoembolization in patients with multifocal BCLC-A and Child-Pugh B
113. THU-113 - Prediction for gastrointestinal bleeding in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
114. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns
115. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma
116. Lack of association between hepatitis B virus pre-S mutations and recurrence after surgical resection in hepatocellular carcinoma
117. Fibroblast growth factor isotype expression pattern and its association with overall survival in patients with hepatocellular carcinoma: 1277
118. Prognostic Impact of Alpha-Fetoprotein Expression in Liver Transplant Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: 625
119. Additive Benefit of Transarterial Chemoembolization and Sorafenib in Treating Advanced-Stage Hepatocellular Carcinoma: Propensity analysis: 572
120. Is HBsAg Seroclearance Following Nucleoside Analogue Therapy Durable in Patients with Chronic Hepatitis Bβ: 313
121. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: Analysis of biopsies of living liver donors
122. rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
123. Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area
124. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
125. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?
126. Argininosuccinate Synthase 1 Suppresses Tumor Progression Through Activation of PERK/eIF2α/ATF4/CHOP Axis in Hepatocellular Carcinoma
127. A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma
128. An index based on deep learning–measured spleen volume on CT for the assessment of high-risk varix in B-viral compensated cirrhosis
129. Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
130. Regorafenib versus nivolumab after sorafenib failure: real-world data in patients with hepatocellular carcinoma
131. Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
132. The quick sepsis-related organ failure score has limited value for predicting adverse outcomes in sepsis patients with liver cirrhosis
133. Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma
134. Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
135. Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study
136. Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
137. Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
138. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation
139. Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone†
140. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion
141. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy
142. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression
143. Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.
144. Identification of Hepatitis C Virus Genotype 6 in Korean Patients by Analysis of 5′ Untranslated Region Using a Matrix Assisted Laser Desorption/Ionization Time of Flight-Based Assay, Restriction Fragment Mass Polymorphism
145. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients
146. Transforming growth factor-beta1 overexpression may be closely related to the invasiveness of hepatocellular carcinoma: 160
147. Clinical characteristics of patients with diffuse infiltrative hepatocellular carcinomas in a hepatitis B- endemic areaclinical characteristics of patients with diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: APASL\Abstract\247
148. Therapeutic Efficacy of Transcatheter Arterial Chemoembolization as Compared With Hepatic Resection in Hepatocellular Carcinoma Patients With Compensated Liver Function in a Hepatitis B Virus–Endemic Area: A Prospective Cohort Study
149. IDDF2019-ABS-0257 Factors and models for predicting posthepatectomy liver failure in patients undergoing hepatic resection for hepatocellular carcinoma
150. FRI-380-Factors and models for predicting posthepatectomy liver failure in patients undergoing hepatic resection for hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.